Roche said the test strips are expired or nearly expired products that are repackaged with counterfeit labels bearing Roche's ...

Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

The CEO of pharmaceuticals giant Roche said authorities should block the takeover of contract drug manufacturer Catalent by ...

Dyno is also entitled to royalties on net sales of commercial products. Dyno specializes in ... In 2020, Dyno signed its first agreement with Roche to help the drug giant and its subsidiary ...

Roche's Q3 sales rose 9% year over year ... These companies will require a CDMO partner to support the launch of their products in the coming years. Catalent is currently the only CDMO with ...

including any devices which may directly compete with Roche products. Extra financial resources from the acquisition will go toward recruitment, product improvement, and building more ...